Replies to post #232302 on Biotech Values

[DewDiligence]

BMY-CELG’s CVR* -28% on bb2121 RTF letter. For the $9/sh payout to occur to CVR holders, bb2121 must receive FDA approval by 3/31/21 (#msg-145844551).

BMY/BLUE PR on today’s news:
https://www.businesswire.com/news/home/20200513005210/en

There was a CC this morning (I didn’t listen).

*Ticker symbol is BMY-RI on Yahoo Finance.